Clinical Trial

A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of the study is to compare the efficacy and safety of XW003 injection versus semaglutide injection in Chinese adults with obesity
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-09; most recent amendment 2026-04-09.
Status change: Recruiting → Active, Not Recruiting 2026-04-09
Status change: Not Yet Recruiting → Recruiting 2025-08-19
Trial Details
NCT Number NCT07073417
Lead Sponsor Hangzhou Sciwind Biosciences Co., Ltd.
Conditions Obesity, Weight Management
Enrollment 163 participants
Start Date 2025-07-28
Primary Completion 2027-02-27 (estimated)
Study Completion 2027-08-23 (estimated)
Updated on ClinicalTrials.gov 2026-04-13